Frequency Of Obsessive-compulsive Symptoms Research Articles

Online Identification of Obsessive-Compulsive Symptoms and Relevant Factors in Patients with Covid-19 in Turkey During Quarantine

Abstract. Aim: Via online interviews, this study identifies the obsessive-compulsive symptoms (OCSs) of patients diagnosed with Covid-19 and quarantined at home for 14 days, to determine the incidence of these symptoms, to detect OCSs in the early period, and to identify the associated risk factors. Method: This research was designed as a descriptive and cross-sectional study. The study population consisted of patients who had tested positive in the real-time PCR test for Covid-19 and were quarantined at home in the Şanlıurfa Province of Turkey. The study sample comprised 800 patients contacted between January and April 2021. The data were collected online using a questionnaire that included sociodemographic characteristics, questions on postinfection changes, and the Padua Inventory, a valid tool for determining the level of OCSs. Results: The frequency of obsessive-compulsive symptoms during quarantine was calculated as 11.2%, and the mean Padua Inventory score was 48.19 ± 19.17. Conclusion: The results of this study show that patients quarantined at home for 14 days with the diagnosis of Covid-19 are less likely to exhibit obsessive-compulsive symptoms during this period. It also shows that the risk of OCSs was lower particularly in patients who had completed a university or higher education and had no previous psychiatric disease or chronic disease diagnosis.

The Metacognitive Training for obsessive-compulsive disorder: A pilot study

More than 50% of patients with obsessive-compulsive disorder (OCD) do not receive first-line psychological treatment such as cognitive-behavioral therapy with exposure and response prevention. To narrow this treatment gap, there is an urgent need for therapies that are easy to disseminate and highly accepted by patients. The aim of the present pilot study was to evaluate the effectiveness of the Metacognitive Group Training for OCD (MCT-OCD). Fifty patients with OCD participated in the MCT-OCD for 4 weeks during their inpatient stay in a single-arm pilot trial. Patients were assessed before and after the intervention and filled out an online survey 6 months after post assessment. Results showed a decrease in obsessive compulsive symptoms according to the Yale-Brown Obsessive Compulsive Scale (primary outcome) from baseline to post assessment with a large effect size. Symptom reduction remained stable over 6 months and was positively correlated with appraisal ratings of the training. The reduction in frequency of obsessive compulsive symptoms, distress due to obsessive compulsive symptoms, cognitive biases, and depressive symptoms remained stable over 6 months after the intervention. Our findings tentatively imply that the MCT-OCD is a promising treatment for OCD patients. A randomized controlled trial is thus warranted to further clarify the efficacy of the MCT-OCD. Trial Registration: German Clinical Trials Register (DRKS-ID: DRKS00012531), date of registration: 16.06.2017.

Frequency of obsessive-compulsive symptoms and related factors in medical and dental students of Kurdistan University of Medical Sciences, 2018

Frequency of obsessive-compulsive symptoms and related factors in medical and dental students of Kurdistan University of Medical Sciences, 2018

Obsessive-Compulsive Symptoms in Schizophrenia: Their Relationship With Clinical Features and Pharmacological Treatment

The aim of this study was to evaluate (1) the frequency of obsessive-compulsive symptoms (OCS) in patients with schizophrenia, (2) the impact of OCS on clinical features of schizophrenia, and (3) the association between type of antipsychotic treatment and presence of OCS. OCS were evaluated using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) in 70 patients with schizophrenia. The patients were then divided into two subgroups: those with at least a moderate level of OCS and those with mild or absent OCS. The two subgroups were compared using scores on the Scale for the Assessment of Positive Symptoms (SAPS), the Scale for the Assessment of Negative Symptoms (SANS), and the Global Assessment of Functioning Scale (GAF). Of the 70 patients with schizophrenia who were evaluated, 36 (51.4%) had at least moderate OCS (Y-BOCS score >16). SAPS subscale scores for hallucinations and delusions and GAF scores were found to be significantly higher among patients with at least moderate OCS, compared with those with mild or absent OCS. A significant relationship between at least moderate OCS and treatment with conventional antipsychotics was also observed. The presence of OCS seems to have the potential to affect clinical outcomes in schizophrenia and treatment with conventional antipsychotics appears to be correlated with the presence of OCS.

Obsessive-compulsive symptoms in children with eating disorders: A preliminary investigation

Abstract A high frequency of obsessive-compulsive symptoms has been noted in adults with eating disorders. Childhood presentations of eating and obsessive-compulsive disorders are thought to be similar to the presentations of these disorders in adulthood. Therefore, it was hypothesized that children with eating disorders would show a high frequency of obsessive-compulsive symptoms. A retrospective examination of the case notes of 131 children with eating disorders revealed a high concurrence (11.5%) of obsessive-compulsive symptoms, especially in boys with anorexia nervosa.